Clover Health Investments Corp. (CLOV), a physician-enabling technology company, on Wednesday reported first quarter financial results, and provided an outlook for 2026.
Q1 2026:
Clover recorded net revenues of $749.2 million in Q1 2026, 62.1% higher than the $462.3 million reported a year ago.
The company showed a positive generally accepted accounting practices (GAAP) net income at $27 million, an improvement of $29 million from the prior year.
Net losses were $27.3 million, while in Q1 2025, losses were $1.3 million.
Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) were $40.3 million in the first quarter, 56.2% higher than the EBITDA of $25.8 million in the previous year.
Consolidated gross profits were at $160 million.
Cash, cash equivalents, and marketable securities held by the company on March 31, 2026, amounted to $418.2 million.
The average Medicare advantage membership saw a growth of 51% from 101,959 in Q1 2025, to 155,773 in Q1 2026.
2026 Outlook:
The company reiterated its outlook for 2026, setting a revenue growth of 49%, to reach $2.81 billion - $2.92 billion, considerably higher than the full-year revenue of $1.92 billion in 2025.
GAAP net income is set at $0-$20 million.
Adjusted EBITDA is estimated to reach $50 million to $70 million, compared to $21.7 million in 2025.
Consolidated gross profits are forecast at $470 million to $510 million, compared to $355.9 million in 2025.
Average Medicare advantage membership is expected to grow by 46% to reach 154,000- 158,000.
CLOV is trading at $2.85, up 6.54%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.